Form 4: iBio Director Gary Sender Acquires 18,900 Stock Options

iBio director Gary Sender acquired 18,900 stock options on November 21, 2024, which vest monthly over twelve months.

Summary

• Gary Sender, a director at iBio, Inc., acquired 18,900 stock options on November 21, 2024.
• The options have an exercise price of $2.45.
• These options vest pro rata on a monthly basis over twelve months, starting from the grant date.
• The options expire on November 20, 2034.

Sentiment

Score: 6

Explanation: The document reflects a routine transaction, a stock option grant to a director, which is neither particularly positive nor negative. It's a standard practice.

Positives

• The acquisition of stock options by a director can be seen as a positive sign of confidence in the company's future.

Industry Context

This is a standard transaction for a director of a public company, often part of their compensation package.

Comparison to Industry Standards

• Stock option grants to directors are a common practice in publicly traded companies, used to align their interests with those of shareholders.
• The vesting schedule of 12 months is also a typical arrangement.

Stakeholder Impact

• The stock option grant aligns the director's interests with those of shareholders, potentially encouraging actions that increase shareholder value.

Key Dates

Keywords

stock options, insider trading, director, iBio, equity, compensation